1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T76849 | Bamlanivimab | ||
Bamlanivimab, an Anti-Human SARS-CoV-2 monoclonal antibody (mAb), was the first of its kind to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020 for COVID-19 trea... |